Informações:
Falhas:
ID
12457
Descrição
The study will compare the safety and efficacy of prasugrel, administered at different doses with clopidogrel in the treatment of Asian participants with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention. (https://clinicaltrials.gov/ct2/show/NCT00830960)
Link
https://clinicaltrials.gov/ct2/show/NCT00830960
Palavras-chave
Versões (2)
- 28/07/2015 28/07/2015 -
- 20/11/2015 20/11/2015 -
Transferido a
20 de novembro de 2015
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Antiplatelet Therapy Acute Coronary Syndrome NCT00830960
Similar models
Eligibiltiy Critera
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Acute coronary syndrome
Item
A person who has been diagnosed with acute coronary syndrome (ACS) and is to undergo a percutaneous coronary intervention (PCI)
boolean
C0948089 (UMLS CUI-1)
PCI
Item
A person who has been diagnosed with acute coronary syndrome (ACS) and is to undergo a percutaneous coronary intervention (PCI)
boolean
C1532338 (UMLS CUI-1)
Race
Item
A person who is of East or Southeast Asian descent
boolean
C0034510 (UMLS CUI [1])
Age
Item
A person who is of the legal age of 18 (or age 21 in Singapore)
boolean
C0001779 (UMLS CUI-1)
Informed consent
Item
Is mentally competent to provide a signed written informed consent before entering the study
boolean
C0021430 (UMLS CUI-1)
Pregnancy
Item
If a woman is of childbearing potential, she must test negative for pregnancy
boolean
C0549206 (UMLS CUI-1)
Birth control
Item
agree to use a reliable method of birth control
boolean
C0700589 (UMLS CUI-1)
cardiogenic shock
Item
cardiogenic shock
boolean
C0036980 (UMLS CUI-1)
ventricular arrhythmia
Item
ventricular arrhythmias
boolean
C0085612 (UMLS CUI-1)
congestive heart failure
Item
congestive heart failure
boolean
C0018802 (UMLS CUI-1)
Bleeding risk
Item
A person who is at an increased risk of bleeding (e.g. active internal bleeding, history of bleeding disorder, recent fibrinolytic therapy before randomization into the study)
boolean
C3251812 (UMLS CUI-1)
History of stroke
Item
History of ischemic or hemorrhagic stroke
boolean
C0559159 (UMLS CUI-1)
intracranial neoplasm
Item
intracranial neoplasm
boolean
C1527390 (UMLS CUI-1)
arteriovenous malformation
Item
arteriovenous malformation
boolean
C0003857 (UMLS CUI-1)
aneurysm
Item
aneurysm
boolean
History of TIA
Item
prior history of transient ischemic attack (TIA)
boolean
C0455536 (UMLS CUI-1)
antiplatelet therapy
Item
A person who needs to take other antiplatelet therapy other than Aspirin for the duration of the study
boolean
C1096021 (UMLS CUI-1)
NSAID
Item
A person who receives daily treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) or cyclooxygenase-2 (COX2) inhibitors that cannot be discontinued
boolean
C0003211 (UMLS CUI-1)
liver failure
Item
A person who has a severe liver disease, such as cirrhosis
boolean
C0085605 (UMLS CUI-1)
Alcoholism
Item
Alcoholism
boolean
C0038586 (UMLS CUI [1])
mental disorders
Item
mental illness
boolean
C0004936 (UMLS CUI-1)
drug dependence
Item
drug dependence
boolean
C1510472 (UMLS CUI-1)